If not, please take a few moments to fill out the form below. It’s free, and ensures that you receive regular alerts to the latest clinical news and other content.

Keep me logged in Forgot your password?

Please wait...

Please wait...

Focal Segmental Glomerulosclerosis (FSGS)

Steroids May Harm Athletes' Kidneys

March 02, 2010

Serious renal damage is a possible consequence of long-term abuse of anabolic steroids, data show .
 

Mycophenolate Mofetil Works As Well As Standard Therapy

July 22, 2008

Six months of mycophenolate mofetil (MMF) treatment is as effective in the short term as conventional therapy for primary treatment of membranous nephropathy (MN) and focal segmental glomerulosclerosis (FSGS), a pilot study in India found.
 

MMF Similar to Conventional Therapies for MN, FSGS

January 01, 2008

A six-month course of treatment with mycophenolate mofetil (MMF) is as effective as conventional therapies for treating membranous nephropathy (MN) and focal segmental glomerulosclerosis (FSGS), according to a pilot study conducted in India.
 

Diagnosing, Treating FSGS: An Update

By Gerald B. Appel, MD, and Alice Sue Appel, PhD March 01, 2007

Focal segmental glomerulosclerosis (FSGS) is not a single disease but a histologic pattern of renal damage that initially affects the glomerulus and its tubulointerstitium.
 

Study Reveals Epidemiology of Glomerulopathies in Brazil

January 01, 2007

Five-year data gathered by the Paulista Registry of Glomerulopathies in São Paulo, Brazil, shows that focal and segmental glomerulosclerosis is the most common primary glomerular disease, followed by membranous nephropathy and IgA nephropathy.
 

Newsletters

Sign up to start receiving free e-newsletters from Renal & Urology News, including:

  • Latest News
  • Latest CME
  • Ongoing Clinical Trials
  • Conference Highlights
  • Expert Q&A
Kidney Week 2011

Our exclusive coverage of Kidney Week 2011 in Philadelphia includes interviews, videos and noteworthy clinical reports.

Sections: Anemia | Transplantation
Secondary Hyperparathyroidism | General News
More: Videos

 Subscribe to the RSS for this page  [view all our RSS feeds here]

 

© 2012 Haymarket Media, Inc.

This material may not be published, broadcast, rewritten or redistributed in any form without prior authorization.

Your use of this website constitutes acceptance of Haymarket Media's Privacy Policy and Terms & Conditions